Connect with us

Emerging Markets

Kona Gold Solutions Inc (OTCMKTS: KGKG) Powerful Run Northbound as Beverage Operator Reports Record Revenues & Launches its New Sparkling Ooh La Lemin Lemonades

Published

on

Kona Gold Solutions Inc (OTCMKTS: KGKG) is making a parabolic run up the charts in recent days on a massive surge in volume. Beverage stocks have a long history of making big moves in small caps and kGKG has been no exception running from under a penny to $0.15 highs in 2020 and the recent powerful reversal. KGKG revenues have incrsased shareply with the Company recently reporting it generated revenues of over one million dollars in the first quarter of 2022, a first for the Company. Kona Gold Beverage has hit or exceeded its monthly revenue projections for the first two months of 2022. Kona Gold has set 2022 revenue projections at $8-$10 million. 

Recently Kona Gold launched its new Ooh La Lemin Sparkling Lemonade. Gluten and GMO-free Ooh La Sparkling Lemonade is available in six delicious flavors: Blue Raspberry, Citrus Splash, Cucumber Watermelon, Huckleberry, Original, and Pineapple Mango. Ooh La Lemin Sparkling will hit Walmart and mortar stores in June. Kona Gold Beverage is laying the ground work to have a phenomenal year with both of its subsidiaries.  The Company is seeing demand grow on a daily basis for its Ooh La Lemin Lemonades and new Sparkling Lemonades.  The rebranding of the Company’s popular hemp energy drink, Kona Gold, will debut in Q2. In addition, the Company anticipates to see big revenue growth in Q2 with its beverage brands and has forecasted out production in 2022 to keep up with demand. 

Kona Gold Solutions Inc (OTCMKTS: KGKG) is a premium lifestyle brand focused on creating great tasting, healthy beverages that consumers demand. Kona Gold Beverage is a leader in the hemp and CBD beverage sector, creating category leading hemp energy drinks and CBD energy waters with its Kona Gold, Highdrate, and Storm brands.  Ooh La Lemin, the Company’s superior lemonade brand, is a category leader and favorite among consumers.  Kona Gold Beverage is a multi-faceted company in the way that it operates its own distribution company to bring products to consumers via traditional retail.  E-commerce, direct ship, distribution partnerships, among others are additional channels Kona Gold Beverage has access to.  The Company operates websites konagoldbeverage.com, konagoldhemp.com, highdrateme.com, oohlalemin.com, and goldleafdist.com. 

KGKG continues to make huge moves; its popular Ooh La Lemin Lemonades will now be sold in Walmart brick and mortar stores. The Company’s 16 oz Ooh La Lemin Lemonades, available in 4 flavors, will be included in modular sets in all stores with 12 ft or wider coolers in select states starting in June of 2022. The Company will announce which states at a later date as it gets closer to launch. The 4 flavors of Ooh La Lemin will be in Walmart’s system nationwide, which will give the Company fire power to secure distribution in states where it’s currently lacking. This is a huge step forward for Kona Gold Beverage as the Company focuses on taking its brand portfolio nationally. The Company’s Ooh La Lemin Lemonades are currently sold in popular chains such as Wawa, Plaid Pantry, Piggly Wiggly, Coborn’s, Hyvee, and others. 

Kona Gold Beverage is laying the ground work to have a phenomenal year with both of its subsidiaries. The Company is seeing demand grow on a daily basis for its Ooh La Lemin Lemonades and new Sparkling Lemonades. The rebranding of the Company’s popular hemp energy drink, Kona Gold, will debut in Q2.  

Gold Leaf Distribution, the Company’s distribution subsidiary, continues to be a bright spot within the Company and has experienced unprecedented growth as it becomes one of the largest distributors in South Carolina. Gold Leaf now distributes to Target, Quik Trip, Piggly Wiggly, IGA, and soon-to-be other big box and grocery stores. To keep up with growth, Gold Leaf continues to hire personnel and purchase delivery trucks. 

KGKG launched its all-new Sparkling Ooh La Lemin Lemonades. Sparkling Ooh La Lemin is formulated with all natural ingredients, contains zero sugar, high in vitamin C, GMO and gluten-free, made with real fruit juice, and only 10 calories. This is the Company’s first all-natural beverage line as it continues to create leading products in the better-for-you space. The Company recently exhibited at the 2022 SE Petro Show in Myrtle Beach, SC and the Sparkling Ooh La Lemin Lemonades were a huge hit with buyers, store owners, and distributors that sampled them at the Company’s booth. Sparkling Ooh La Lemin comes in 12 oz sleek cans and is available in 6 delicious flavors: Blue Raspberry, Citrus Splash, Cucumber Watermelon, Huckleberry, Original, and Pineapple Mango. 

To Find out the inside Scoop on KGKG Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

KGKG

The Company is already in the process of working with buyers at several national big box stores and large grocery chains in the Southeast United States. Being that Sparkling Ooh La Lemin is an all-natural beverage, this also creates opportunities for the Company to approach health conscience grocery chains. The Company’s team is currently working on setting up meetings with buyers at the leading chains in this health category. Sparkling Ooh La Lemin can be immediately purchased from the Company’s Ooh La Lemin website and will be available on Amazon and Walmart Marketplace in the coming days. 

Gold Leaf Distribution, has begun to sell the Company’s new Sparkling Ooh La Lemin Lemonades into Walmart stores in South Carolina. There are 110 Walmart store locations in South Carolina and Gold Leaf Distribution has been tasked to sell all 6 new flavors of Sparkling Ooh La Lemin Lemonades into those stores. The Company’s new 12 oz Sparkling Ooh La Lemin Lemonades are also authorized in all Walmart stores nationwide. 

On April 4 KGKG announced the Company had revenues of over one million dollars in the first quarter of 2022. This marks the Company’s first quarter of one million dollars or more, which is a huge milestone and testament to the continued growth it’s experiencing. Kona Gold Beverages two subsidiaries, Kona Gold LLC and Gold Leaf Distribution LLC’s combined revenue broke the one-million-dollar mark in Q1. Gold Leaf Distribution, the Company’s distribution subsidiary, continues to have record month-over-month revenue and March was no exception. March revenue projections for Gold Leaf were $260,000 and the Company did approximately $310,000 in revenue, exceeding projections by approximately 19%. In addition to this announcement, Kona Gold Beverage has hit or exceeded its monthly revenue projections for the first two months of 2022 and will be sharing February numbers with shareholders in the coming days. The Company has set 2022 revenue projections at $8-$10 million. 

Microcapdaily has been reporting on KGKG for years but our report from March 10, 2022 when KGKG as trading in the $0.004 range really hit it on the head with KGKG moving over 100% since making that reversal. 

For More on KGKG Subscribe Right Now!

Currently trading at a $27.4 million market valuation KGKG has 1,299,543,929 shares outstanding, some debt on the books and $550,000 in the treasury. KGKG is an exciting story developing in small caps; Gold Leaf Distribution, the Company’s distribution subsidiary, continues to be a bright spot within the Company and has experienced unprecedented growth as it becomes one of the largest distributors in South Carolina. Gold Leaf Distribution, has begun to sell the Company’s new Sparkling Ooh La Lemin Lemonades into Walmart stores in South Carolina. There are 110 Walmart store locations in South Carolina and Gold Leaf Distribution has been tasked to sell all 6 new flavors of Sparkling Ooh La Lemin Lemonades into those stores. The Company’s new 12 oz Sparkling Ooh La Lemin Lemonades are also authorized in all Walmart stores nationwide. Kona Gold Beverage has hit or exceeded its monthly revenue projections for the first two months of 2022. Kona Gold has set 2022 revenue projections at $8-$10 million. KGKG has massive momentum here, powerful volume and a significant gap to fill from current levels. We will be updating on KGKG when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with KGKG.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in KGKG either long or short and we have not been compensated for this article.

 

 

Emerging Markets

Strong Financials and Social Media Buzz Propel Forza X1, Inc. (NASDAQ:FRZA) to New Heights

Published

on

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023.

Forza X1, Inc. (Nasdaq: FRZA) shares witnessed an exceptional and unforeseen surge in its share price, skyrocketing by 151% early morning of June 5th, 2023. This surge was accompanied by an unprecedented level of trading volume, marking a significant departure from the previously observed average. Notably, the stock’s trading volume had been relatively low in recent months, with numerous days experiencing trading activity of less than 1,000 shares. Without any apparent news or filings, the cause behind this sudden surge remains a subject of intrigue and speculation among market participants.

What happened?

Firstly it’s important to note that $FRZA is a spin-off of Twin Vee PowerCats Co. (Nasdaq: VEEE). $VEEE is the parent company handling the design, manufacturing, and distribution of recreational and commercial, off-shore power catamaran boats while $FRZA is the new developer of electric sport boats with a mission to accelerate the adoption of sustainable recreational boating.

To Discover the Inside Scoop on FRZA, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Upon examination of the company, no discernible filings or press releases have been identified to account for today’s remarkable shift. However, it seems that a tweet disseminated by the company caught the attention of retail investors, subsequently generating an enormous surge in trading volume.

This recent occurrence serves as yet another compelling demonstration of the significant impact that the retail community can exert when armed with information regarding a small float micro-cap stock, particularly when the conditions align favorably and validate the potential for substantial gains. The tweet, skillfully crafted by the company’s social media team, featured a compelling GIF and clever “Don’t miss the boat” blurb, demonstrating a keen understanding of their business’s essence. 

The timely and engaging content proved to be a perfect execution, capturing the attention and imagination of investors in a manner that resonated deeply with the nature of the company’s operations.

Overview of Twin Vee PowerCats Co. Financials

Could the surge in share price also reflect the market’s enthusiastic response to Twin Vee’s strong financial results for the first quarter of 2023? 

On May 15, 2023, Twin Vee PowerCats Co. released its financials demonstrating a substantial increase in net revenue and notable improvements in the gas-powered boat segment.

https://twitter.com/JohnZidar/status/1665685698400141313?s=20

Twin Vee PowerCats Co. (Nasdaq: VEEE) reported strong financial results for the first quarter ended March 31, 2023. The company experienced a notable 51% increase in net revenue, reaching $8.9 million compared to $5.9 million in the same period last year. The gas-powered boat segment achieved a net income of $181,000, significantly improving from the net loss of $626,000 in Q1 2022.

However, as per GAAP accounting policy, Twin Vee’s consolidated financial statements resulted in a total net loss of $1.8 million for the quarter, primarily due to their majority ownership in Forza X1, Inc. (Nasdaq: FRZA), an electric boat company. Twin Vee reported cash, cash equivalents, restricted cash, and marketable securities of approximately $12.6 million as of March 31, 2023.

The company has been expanding its product lineup, including introducing the Aquasport mono-hull boat brand. Twin Vee is confident these efforts will contribute to business scalability and brand growth. They aim to optimize inventory levels and production costs while closely monitoring market conditions, dealer inventories, and economic indicators.

Financial highlights for Q1 2023

  • Total revenue: $8,877,000 (51% increase compared to Q1 2022)
  • Gross profit: $3,222,000
  • Net income from gas-powered boats segment: $182,000
  • Net loss from Forza X1 (electric boat entity): $2,005,000
  • Loss from Fix My Boat (franchise business): $5,000
  • Adjusted net loss (excluding non-cash charges): $1,347,000
  • Adjusted net income from gas-powered boats segment: $265,000

Twin Vee’s consolidated cash, cash equivalents, restricted cash, and marketable securities were $23,457,000 as of March 31, 2023. Forza X1 reported $10,683,000 in the same category, while Twin Vee’s core business had $12,643,000, and Fix My Boat had approximately $132,000.

We will closely monitor the performance of Forza X1, Inc. (Nasdaq: FRZA) in the coming weeks, considering that it is a spinoff from its parent company. It is crucial to conduct thorough research, particularly for companies like FRZA that have yet to achieve profitability. However, it is worth noting that the parent company has been making notable progress, as evidenced by its recent financial results, which revealed a substantial increase in the bottom line.

We will update you on FRZA when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Sasin Tipchai from Pixabay

Continue Reading

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.